To evaluate the effect of the melatonin-MT2 pathway on HO formation in vivo, both melatonin and the MT2 receptor selective inhibitor 4-P-PDOT were administered to rats with Achilles tendon injuries, and we saline treatment and normal rats were used as controls. Here, MTNR1B is linked to Achilles tendon injury.